Angelini Pharma patents expiration

1. Oleptro patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8133893 ANGELINI PHARMA Trazodone and trazodone hydrochloride in purified form
Mar, 2029

(5 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7829120 ANGELINI PHARMA Trazodone composition for once a day administration
Mar, 2027

(3 years from now)

Drugs and Companies using TRAZODONE HYDROCHLORIDE ingredient

Market Authorisation Date: 02 February, 2010

Treatment: Method of treating depression


How can I launch a generic of OLEPTRO before it's drug patent expiration?
More Information on Dosage

OLEPTRO family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic